| 2020-12-21 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive Vice President & CMO | 92,694 0.1378% | $17.54 | $1.63M | +30.58% | |
| 2020-12-14 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive Vice President & CMO | 107,306 0.1499% | $15.94 | $1.71M | +34.62% | |
| 2018-06-18 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive VP R&D, CMO | 120,000 0.2321% | $54.39 | $6.53M | -28.09% | |
| 2017-09-07 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive Vice President R&D | 95,000 0.1814% | $46.59 | $4.43M | -7.37% | |
| 2015-07-28 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive Vice President R&D | 2,350 0.0048% | $21.20 | $49,827 | -22.75% | |
| 2015-07-13 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive Vice President R&D | 1,950 0.0041% | $19.23 | $37,499 | -13.48% | |
| 2015-06-12 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive Vice President R&D | 2,051 0.0043% | $18.27 | $37,472 | -9.83% | |
| 2015-06-11 | Sale | Supernus Pharmaceuticals, Inc. SUPN | Executive Vice President R&D | 3,631 0.0077% | $16.39 | $59,521 | +0.59% |